6505--Lamotrigine Tablets Jubilant Cadista Pharmaceuticals, Inc. Base Ordering Period 6/16/2025 - 6/15/2026

Award Notice Posted

Solicitation number
36E79725R0004
Agency
Awarded
to Jubilant Cadista Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
36E79725D0029 Federal IDV award

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs National Acquisition Center has awarded contract 36E79725D0029 to Jubilant Cadista Pharmaceuticals Inc. for Lamotrigine Tablets, with a base ordering period spanning from June 16, 2025 to June 15, 2026. The contract, valued at $11,913,264.25, was officially awarded on April 16, 2025, and does not have a specific set-aside status. Located in Yardley, PA, Jubilant Cadista Pharmaceuticals will supply these pharmaceutical tablets under the contract, with Ray Roldan serving as the contract specialist and point of contact from the Hines, IL contracting office.

Notice text

Awarded contract 36E79725D0029 to JUBILANT CADISTA PHARMACEUTICALS INC. for 11913264.25 on 2025-04-16.

Files

File Type Posted
36E79725D0029_1.docx DOCX document

Notice history

Notice Type Posted
This notice Award Award Notice
6505--Lamotrigine Immediate Release (IR) Tablets Latest solicitation Solicitation
6505--Lamotrigine Immediate Release (IR) Tablets Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors